本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioCorRx Inc.

0.4000
0.0000
成交量:- -
成交额:- -
市值:947.41万
市盈率:-1.23
高:0.4000
开:0.4000
低:0.4000
收:0.4000
52周最高:0.5000
52周最低:0.1995
股本:2,368.53万
流通股本:859.99万
量比:0.53
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.3253
每股收益(LYR):-0.4880
净资产收益率:145.76%
总资产收益率:-82.89%
市净率:-0.70
市盈率(LYR):-0.82

数据加载中...

公司资料

公司名字:
BioCorRx Inc.
交易所:
PINK
成立时间:
2009
员工人数:
3
公司地址:
2390 East Orangewood Avenue,Suite 570,Anaheim,California,United States
邮编:
92806
电话:
传真:
- -
简介:
BioCorRx Inc. is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx Inc. is a one-on-one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The Company also has an R&D subsidiary, BioCorRx Pharmaceuticals, which is currently developing injectable and implantable naltrexone products for potential future regulatory approval. For more information on BICX, visit www.BioCorRx.com.